T cells from patients with human immunodeficiency vi-

CD30 is found on Reed-Sternberg cells of Hodgkin's rus (HIV) infection and on CD4 ϩ T cells from allergic disease and on a variety of non-Hodgkin's lymphoma
patients (Manetti et al., 1994; Maggi et al., 1994 ; Pizzolo cells and is up-regulated on cells after Epstein- Barr et al., 1994; Del Prete et al., 1995) .
In vitro, CD30 is upvirus, human T cell leukemia virus, and HIV infections. regulated on T and B lymphocytes after activation with We report here that the thymus in CD30-deficient mice mitogen, on Epstein-Barr virus (EBV)-transformed B contains elevated numbers of thymocytes. Activationcells, and on human T cell leukemia virus I (HTLV-I)-induced death of thymocytes after CD3 cross-linking and HTLV-II-transformed lymphocytes (Andreesen et al., is impaired both in vitro and in vivo. Breeding the CD30
1984; Stein et al., 1985; Schwarting et al., 1989 ; Ellis et mutation separately into ␣␤TCR-or ␥␦TCR-transgenic al., 1993) . mice revealed a gross defect in negative but not Histochemical staining of healthy tissues has shown positive selection. Thus, like TNF-receptors and that CD30 expression is largely restricted to lymphoid compartments, predominantly around B cell follicles Fas/Apo-1, the CD30 receptor is involved in cell death and at the edge of germinal centers in lymph nodes and signaling. It is also an important coreceptor that parspleen (Stein et al., 1985) . CD30 is also found in the ticipates in thymic deletion.
thymic medulla (Stein et al., 1985; Schuurman et al., 1989) . CD30 is not detected on cells of the peripheral Introduction blood or on resting lymphocytes (Ellis et al., 1993) . A ligand for CD30 (CD30L) has been cloned and found to CD30 was originally identified on mononucleated Hodgshare sequence similarities with other members of the kin's (H) and multinucleated Reed-Sternberg (RS) cells emerging TNF/NGF cytokine family (Smith et al., 1993) . in Hodgkin's disease (HD) There are few reports on tissue distribution of CD30L, al., 1982) . Over the past decade, CD30 has also been although it appears to be expressed on activated T cells found on malignant cells from numerous non-HD lymand macrophages (Smith et al., 1993; Gruss et al., 1994) . phomas and other malignancies. It is also expressed on Defective ligand-receptor systems involving the TNFR some virus-infected cells. The presence of CD30 under family of molecules are known to result in diseases. For this broad range of pathological conditions has thus example, mutations in the CD40L gene in humans results suggested a role for CD30 in disease.
in an X-linked immunodeficiency hyper-immunoglobulin CD30 is a 120 kDa type I cell surface glycoprotein M (IgM) syndrome (Aruffo et al., 1993; Korthauer et al. , that also exists in some situations in the plasma as a 1993; DiSanto et al., 1993; Allen et al., 1993) , and defects soluble 84 kDa protein (Froese et al., 1987 ; Nawrocki in the Fas-Fas ligand system are implicated in autoimet al., 1988) . The extracellular domain of CD30 shares mune disease in mice (Watanabe-Fukunaga et al., 1992 ; sequence similarity with other tumor necrosis factor Lynch et al., 1994; Takahashi et al., 1994) . (TNF)/nerve growth factor (NGF) receptor superfamily
In vitro studies have shown that CD30 can mediate a members, including p55 and p75 TNF receptors, the low variety of activation and differentiation signals, a capacaffinity NGF receptor, 4-1BB, OX40, CD27, CD40, and ity that varies with cell type and origin. Engagement of the Fas/Apo-1 antigen (Dü rkop et al., 1992) . All family CD30 on cell lines has been shown to induce immunomembers are transmembrane proteins that contain exglobulin secretion in EBV-transformed lymphoblastoid tracellular cysteine-rich repeats (Dü rkop et al., 1992) . cells, proliferation in T cell-like HD-derived cells, null However, there is no sequence similarity in the cytoresponse in B cell-like HD-derived cells, or cell death plasmic region between CD30 and other TNF superfamin ALCL cells (Smith et al., 1993; Gruss et al., 1994) . In ily members, and the cytoplasmic domain of CD30 does addition, different anti-CD30 antibodies with both agonist and antagonist effects on CD30 ϩ cells have been not appear to contain the death domain of Fas or other genomic clone isolated from a 129/J library. The 0.4 kb HindIII fragment containing the second-last exon of the CD30 gene was replaced by a neomycin (neo) gene cassette containing a poly(A) termination signal (pMC1neo-polA), placed in an antisense orientation. The linearized construct was introduced into E14K embryonic stem cells by electroporation, and G418-resistant embryonic stem colonies were screened for homologous recombination by polymerase chain reaction and B220 ϩ cells, including expected numbers of CD4 ϩ and CD8 ϩ T cell subpopulations (Table 2) . Thus, CD30 deficiency does not result in overt defects in homeostadescribed. The observations that CD30 has pleiotropic effects on different cells in vitro has made it difficult to sis in either B or T cell lineages. However, CD30 is upregulated on T cells after activation. We examined prolifsuggest a function for CD30 in vivo. Here we show that mice deficient for CD30 expression after gene targeting erative responses of enriched T cells from lymph nodes of CD30 mutant mice, which were similar to controls manifest a defect in thymocyte negative selection. Thus, our data indicate that CD30 functions similarly to Fas after activation with anti-CD3 MAb, phorbol myristate acetate (PMA)-calcium ionophore, or staphylococcal and TNFR in mediating cell death signals. While Fas and TNFR operate mainly in mature T cells, CD30 appears to enterotoxin B (SEB) (Figure 2 ). The CD30 mutation also did not have any effect on apoptotic cell death of periphbe the primary death-signaling molecule in thymocytes.
eral T lymphocytes in activation assays or after in vivo stimulation with SEB (data not shown). In mature T cells, Results CD30 does not appear to be required for either activation or SEB-induced death signals through the T cell receptor Generation of Gene-Deficient Mice To examine the physiological function of the HD-associ-(TCR). The finding that a portion of CD45RO T cells expresses ated molecule CD30, we generated a mouse line that lacks CD30 expression by means of gene targeting (Fig-CD30 raised the possibility that CD30 might play a role in T cell memory (Ellis et al., 1993). We therefore assessed ure 1). The CD30 targeting vector ( Figure 1A ) was constructed from a 7.2 kb DNA fragment derived from a CD8 ϩ T cell memory in CD30-deficient mice. CD30 Ϫ/Ϫ and Cells from thymi, mesenteric lymph nodes, and spleens were collected and stained with anti-CD4 (PE) and anti-CD8 (FITC) or with anti-Thy-1.2 (PE) and anti-B220 (FITC) and analyzed on a FACScan. Three mice were included in each group.
CD30 ϩ/Ϫ mice were injected intravenously with vesicular against this challenge infection (Bachmann and Kundig, 1994) . VSV-immunized CD30 ϩ/Ϫ and CD30 Ϫ/Ϫ mice were stomatitis virus (VSV). The predominant epitope for CD8 ϩ cytotoxic T lymphocyte (CTL) in H-2 b mice lies resistant to challenge infection, whereas nonimmunized controls succumbed to vaccinia-induced meningitis within the nucleoprotein of VSV (Kundig et al., 1993b; Puddington et al., 1986) . Spleen cells were stimulated (data not shown). Thus, both in vitro and in vivo assays indicated that CD8 ϩ CTL memory was unaltered in the in vitro 10 and 40 days after injection of virus with VSV nucleoprotein (VSV-NP)-transfected antigen-presenting absence of CD30. Basal serum levels for various subclasses of immunocells (Kundig et al., 1993a) . In VSV-immune animals, such restimulation generates CD8 ϩ VSV-NP-specific globulin (IgM, IgG1, IgG2a, IgG2b, and IgG3) were comparable for mutant and control mice (data not shown).
CTL. Spleen cells from CD30
ϩ/Ϫ and CD30 Ϫ/Ϫ mice generated similar cytotoxicity after restimulation ( Figure 3A ).
In addition, we assessed humoral immune responses after infection with VSV. This infection normally induces The biological relevance of this in vitro assay for memory was confirmed in vivo, where mice were intracerebrally a rapid and T help-independent neutralizing IgM response, followed by a T help-dependent IgG class challenged at the same timepoints with vaccinia VSV-NP recombinant virus (Binder and Kundig, 1991) . VSVswitch (Bachmann and Kundig, 1994) . Both IgM responses and class switching to IgG was similarly presspecific CD8 ϩ memory CTL is required to protect mice ent in CD30 Ϫ/Ϫ and CD30 ϩ/Ϫ mice ( Figure 3B ). These data indicate that, in the absence of CD30, B cell function and responses are normal and T help for B cells is unimpaired.
Thymus Is Enlarged in Mutant Mice
CD30 is expressed on small numbers of cells in the thymic medulla (Stein et al., 1985) , a thymic microenvironment where negative selection of thymocytes is known to occur (Surh and Sprent, 1994; Sprent and Webb, 1995) . In addition, a recent study found CD30 mRNA expression to be abundant in the thymus (E. R. Podack, personal communication). We therefore searched for a defect in the thymus of CD30 Ϫ/Ϫ mutant mice. The thymi of CD30 Ϫ/Ϫ mice showed normal T cell ( Table 2) . However, the total number of thymocytes in
Enriched T cells were plated in 96-well flat-bottomed plates at 1 ϫ 10 5 cells per well and stimulated with PMA (15 ng/ml) plus mutant animals was elevated compared with littermates calcium ionophore A23617 (250 ng/ml), SEB (2.5 g/ml), and anti- (Table 1) of thymocytes to dexamethasone and ␥-irradiation, both cortical double-positive (DP) (CD4 ϩ CD8 ϩ ) thymocytes for 24 hr. As a control, thymocytes were cultured without any stimu- (Sellins and Cohen, 1987; Wyllie, 1980; Scollay et al., lations for 24 hr. Viable cells were then counted using trypan blue exclusion and double stained with anti-CD8-FITC and anti-CD4-PE 1984), and found no difference in cell death between
MAbs. Viable cells (10,000) were analyzed using FACScan. Numbers mutant and control mice ( Figure 4A ). We further investi- vitro (Smith et al., 1989) and in vivo (Shi et al., 1991) . By proximately 25-fold increase of DP cells in mutant mice as compared with controls ( Figure 4A ). A similar phenomenon was seen 20 hr after anti-CD3 treatment in after anti-CD3 treatment in vitro were different in their nucleosomal fragmentation pattern, which is charactervivo, where mutant animals showed 4-fold greater numbers of DP thymocytes compared with treated litistic of apoptosis ( Figure 4B ). Thus, it appears that DP thymocytes from CD30 Ϫ/Ϫ mice are less susceptible to termates (data not shown). In agreement with these findings, DNA of thymocytes from control and CD30
Ϫ/Ϫ mice anti-CD3-mediated apoptosis.
Negative Selection in ␣␤TCR-Transgenic CD30
Ϫ/Ϫ Mice Is Defective To investigate the role of CD30 in thymocyte apoptosis, we bred the CD30 Ϫ/Ϫ mutation into TCR-transgenic animals and examined selection processes in the thymus. Treatment of normal thymocytes with anti-CD3 is thought to mimic activation-induced cell death similar to that observed with thymic deletion. Thus, our results above pointed toward a possible defect in negative selection. We hypothesized that defects in negative selection in CD30-deficient mice might only be subtly visible owing to the small fraction of thymocytes that actually undergoes negative selection processes (Table 1) . To increase the fraction of thymocytes subjected to negative selection, we bred the CD30 mutation into TCRtransgenic mice with receptors specific for self-antigen.
An ␣␤TCR-transgenic mouse line specific for the male antigen (H-Y) was bred with the CD30 Ϫ/Ϫ mutant strain. Thymocytes expressing the H-Y-specific transgenic ␣␤TCRs are positively selected in female H-2 b mice, negatively selected in male H-2 b mice, and nonselected in H-2 d mice (Teh et al., 1988; von Boehmer, 1990) . Thymocyte phenotypes were similar in positive-selecting CD30 Ϫ/Ϫ and CD30 ϩ/Ϫ mice, as defined by anti-CD4 and anti-CD8 antibodies and staining for the transgenic TCR V␤8.2 chain ( Figure 5A ). Thymocytes from these animals also showed similar expression of heat-stable antigen (HSA), CD69, Pgp-1, and the transgenic TCR V␣ chain (data not shown). In nonselecting transgenic mice, there were also no differences in thymocyte profiles between CD30 Ϫ/Ϫ and CD30 ϩ/Ϫ animals (data not shown).
Conversely, in negative-selecting male H-Y-transgenic mice, we observed a dramatic phenotype in CD30 Ϫ/Ϫ animals ( Figure 5B ). The negative-selecting mice normally show a marked, absolute reduction of thymocyte numbers as well as a proportionate decrease in DP cells (Teh et al., 1988) . In negatively selecting male mice with CD30 Ϫ/Ϫ mutations, the thymus contained an approximately 20-fold increase in DP cells compared with CD30
ϩ/Ϫ mice ( Figure 5B ; Table 3 ). However, there is still about a 3-to 5-fold reduction in thymocyte numbers in CD30 Ϫ/Ϫ mice compared with the thymi of positively selecting (H-2 b ) female mice (Table 3) . Thus, these data indicate that H-Y-transgenic CD30 Ϫ/Ϫ mice have only a partial, but clearly significant, defect in negative selection in the thymus.
On the other hand, lymph nodes and spleen contained similar numbers of lymphocytes in negatively selecting CD30 Ϫ/Ϫ and CD30 ϩ/Ϫ mice ( Table 3 ). The number of T . All mice were age matched. Cells were stained simultaneously with anti-CD8 (FITC) and anti-CD4 (PE) or with anti-Thy-1.2 (PE) and clonotypic T3.70 antibody (rat IgG, supernatant), which recognizes the transgenic TCR V␣ chain. T3.70 antibody was visualized using FITC-labeled goat anti-rat IgG (Southern Biotechnology Associates). In double-staining experiments using T3.70, nonspecific staining due to remaining anti-rat immunoglobulin sites was blocked using 2 g per 100 l of rat IgG (Sigma). Samples were analyzed using a FACScan. Results were expressed as a percentage of T3.70 ϩ cells among Thy-1.2 ϩ cells.
in response to ␥-irradiated spleen cells from male mice showed increased numbers of ␥␦ T cells in these organs (Table 4) b/b mice, transgenic ␥␦ thymoTo assess whether clonal deletion of thymocytes reaccytes are deleted, and fewer than 2% of thymocytes tive to endogenous viral superantigens is also impaired express a ␥␦TCR (Dent et al., 1990 Ϫ/Ϫ mutations, on the other hand, had about 15-fold increased numbers ‫5ف(‬ ϫ 10 6 ) of ␥␦TCR Discussion thymocytes. In these CD30
Ϫ/Ϫ mice, over 95% of the ␥␦TCR ϩ thymocytes also expressed the activation Despite intensive investigation and the association of CD30 with HD and other lymphomas, the cellular funcmarker Pgp-1 ( Figure 6B ) (Skeen and Ziegler, 1993; Tatsumi et al., 1993) . Taken together, the data from both tion of the CD30 molecule in vivo has remained a mystery. Preactivated peripheral T cells and certain HD-␥␦-and ␣␤TCR-transgenic mice demonstrate that in the absence of CD30 negative selection of thymocytes is derived cell lines (expressing T cell markers) have been reported to show enhanced proliferation upon CD30 partially impaired.
Although lymph nodes and spleens contained similar engagement (Smith et al., 1993; Gruss et al., 1994) . We found enriched T cells from CD30 mutant mice to have numbers of lymphocytes in negatively selecting CD30
Ϫ/Ϫ
and CD30
ϩ/ϩ mice, the thymi of CD30 Ϫ/Ϫ mice were connormal proliferative responses after anti-CD3 cross-linking or treatment with mitogens. Spleen cells from mutant sistently severalfold larger. Moreover, the CD30 Ϫ/Ϫ mice mice immunized with VSV also generated normal cytotoxic responses in vitro, suggesting that proliferation and effector functions of T cells were unimpaired. Thus, although CD30 may have the ability to modulate T cell proliferation in vitro, our data indicate that CD30 deficiency does not cause a discernible defect in proliferation and effector functions of T lymphocytes. EBV-immortalized B cell lines have been shown to have enhanced immunoglobulin production and secretion after cross-linking with anti-CD30 antibodies (Gruss et al., 1994) . CD30 has also been found on T helper cell subsets that reportedly exhibit potent helper function for immunoglobulin production (Alzona et al., 1994) . In CD30 mutant mice, basal serum immunoglobulin levels and T helper-dependent IgG class switching against VSV infection were normal, as were T helper-independent IgM responses. As a result, there is no evidence that CD30 is required in either maturation or class switching of normal B cells. This does not preclude a role for CD30, however, in malignant or transformed B cells.
CD30 is expressed on a subset of T cells expressing the isoform CD45RO (Ellis et al., 1993), considered to be a marker of memory T cells (Merkenschlager and Beverley, 1989) . Our finding that both primary and secondary T cell responses were normal in CD30 mutant mice demonstrates that CD30 is not essential in either the production or maintenance (assessed up to 40 days) of memory T cells.
Our findings in this report indicate that CD30 is a surface receptor that influences the outcome of selection events in the thymus. This observation is consistent with the finding that CD30 mRNA expression is mainly found in the thymus (E. R. Podack, personal communication). It is interesting to note that, although we observed a prominent role for CD30 in negative selection of thymocytes, its expression in the thymus does not appear to be extensive. It was reported that CD30 is present on only small numbers of the so-called large cells in the thymic medulla (Stein et al., 1985) . A recent report also shows that apoptotic cell death due to negative selection can be seen in only very few cells in the thymus (Surh and Sprent, 1994 ). Thus, it is possible that CD30 is transiently expressed on thymocytes that are destined to die.
Significant numbers of male antigen-specific H-Ytransgenic T cells are found in the periphery of negatively selecting male mice with either CD30 ϩ/ϩ or CD30 Ramsdell and Fowlkes, 1990 ; Robey and were examined, the numbers of transgenic TCR lympho- Fowlkes, 1994; Schwartz, 1989) . Thus, expression of cytes in the thymus and lymph nodes were elevated in CD30L on thymic dendritic cells might provide a means CD30 Ϫ/Ϫ mice compared with CD30 ϩ/ϩ littermates. These of mediating deletion of autoreactive thymocytes. It is data suggested that the ␥␦ T cells were more likely to noteworthy that bone marrow-derived macrophages escape deletion in the CD30 Ϫ/Ϫ mice. It should be noted express CD30L (Smith et al., 1993) . Alternatively, negathat, in this model, few transgenic ␥␦TCR T cells are tive selection through CD30-CD30L binding might occur normally found in the periphery of mice in the negativeas a result of interactions between thymocytes. In this selecting background (Dent et al., 1990) 
. For both the context, it is interesting that peripheral T cells activated negative-selecting H-Y-and ␥␦TCR-transgenic models, with anti-CD3 antibodies or mitogens up-regulate both transgenic T cells from lymph nodes of CD30
Ϫ/Ϫ mice CD30 and CD30L (Smith et al., 1993) . were shown to be functionally nonresponsive, indicating Since CD30 is a TNFR family member, it was not surthat, in addition to deletional mechanisms, other forms prising that the molecule can be involved in mediating of tolerance induction are operational in CD30 Ϫ/Ϫ mice. death signals. It is intriguing, however, that direct seCuriously, while CD30 is important for clonal deletion quence comparison showed no significant similarities of thymocytes reactive to antigens such as male H-Y and between the CD30 cytoplasmic region and the newly Tla b antigens, CD30 is not required for clonal deletion of defined TNFR family death domain, which is present in thymocytes reactive to the endogenous viral superanti-TNFR p55, Fas antigen, the low affinity NGF receptor, gen, Mls-2 a . In this context, it is interesting to note that, ankyrin, MORT1, TRADD, MORT1/FADD, and RIP in the absence of gp39-CD40 interactions, negative se- (Cleveland and Ihle, 1995) . Although these TNFR molelection of Mls-reactive thymocytes is impaired (Foy et cules all contain death domain homology, they appear to al., 1995). Thus, it is likely that the process of negative mediate death signals with varying kinetics and through selection may involve multiple, and to some extent redifferent mechanisms (Clement and Stamenkovic, 1994) . dundant, costimulation signals.
In light of this, it is likely that CD30, with its highly unique The differential expression of CD30L on thymic cells cytoplasmic domain, might mediate death signals might determine whether positive or negative selection through interactions with a novel protein(s). occurs during thymocyte development. Positive selecFas plays a critical role in the deletion of mature petion is thought to occur on the epithelial cells of the ripheral T cells, but has no known role in negative selection in the thymus (Singer and Abbas, 1994). TNFR p55- (Pfeffer et al., 1993; Erickson et al., 1994; Rothe et al., 1993) , while p75 has been found to mediate
death of mature CD8 ϩ T cells (Zheng et al., 1995) . In our (Teh et al., 1988; von inducing molecule. Thus, CD30 may not be involved in Boehmer, 1990) or ␥␦TCR (V␣11.3J␦1C␦/V␥2J␥1C␥1) transgenic fetumor formation, or may even retard lymphoma develop- Bluestone et al., 1988) .
ment. This latter suggestion might be consistent with plasma (Pizzolo et al., 1990; Gause et al., 1991) . with 70 l of rabbit anti-human IgG antibody (10 g/ml; Southern Biotechnology Associates) for 2 hr at room temperature. Plates were washed three times with PBS and then incubated with 3 ml of PBS Experimental Procedures containing 1% bovine serum albumin (BSA) for 14 hr at 4ЊC. Plates were washed once with PBS and incubated for 1 hr at room temperaCells ture with 400 l of HL-1 medium containing 2% FCS and 2.5 g/ml E14K embryonic stem cells from 129/Ola mice were maintained of mouse CD30L fused to the Fc portion of human IgG (CD30L-Fc; on a layer of mitomycin C-treated embryonic fibroblasts in culture provided by Dr. C. Smith). For controls, plates were incubated in medium (Dulbecco's modified Eagle's medium) supplemented wih HL-1, 2% FCS medium without CD30L-Fc. Plates were then washed leukemia inhibitory factor, 15% FCS, L-glutamine, and ␤-mercaptotwice with PBS. Lymph node cells (2 ϫ 10 6 ) activated with anti-CD3 ethanol.
antibody as described above were cultured in these plates in HL-1 medium containing 2% FCS at 37ЊC for 1 hr. Plates were finally washed three times with PBS, and the number of cells bound to
Generation of CD30
Ϫ/Ϫ Mutant Mice the center portions coated with CD30L-Fc was counted for three Murine cDNA for CD30 was cloned from a mouse T cell cDNA library different microscopic fields (400ϫ). in ZapII (Stratagene) using the human CD30 cDNA (Dü rkop et al., 1992 ) (provided by Dr. H. Stein). The CD30 cDNA clone was partially Flow Cytometric Analysis sequenced and used for screening a mouse genomic library (partial The following MAbs (all obtained from Pharmingen) were used: antiMboI digest of 129/J genomic DNA in DASH phage vectors). Geno-CD4 (FITC labeled or PE conjugated), anti-CD8 (FITC or PE labeled), mic clones were mapped and partially sequenced. A 7.2 kb genomic anti-B220 (FITC labeled), anti-Thy-1.2 (FITC or PE labeled), anti-␥␦ fragment (gCD30) containing two exons of the CD30 gene was used (PE conjugated), anti-V␤3 (PE conjugated), anti-V␤6 (FITC labeled), to construct the targeting vector. A 0.4 kb genomic HindIII fragment anti-V␤8 (PE conjugated), anti-V␤11(FITC labeled), anti-V␤14 (FITC containing the second-last exon was replaced with a neo resistance labeled), anti-V␥2 (FITC labeled), anti-H-2K b (FITC labeled), antigene cassette, pMC1neo-polA (Thomas and Capecchi, 1987) to ob-H-2K d (PE conjugated), and anti-Pgp-1 (PE conjugated). Blood samtain the targeting vector TV30neoA. The neo resistance gene was ples (20 l) were collected in heparinized capillary tubes and washed inserted in antisense orientation to the CD30 transcriptional orientaonce in immunofluorescence staining buffer (PBS, 1% BSA, 0.1% tion and contained a polyadenylation signal ( Figure 1A ). E14 embryNaN 3 ). Single cell suspensions from thymocytes, spleen cells, lymph onic stem cells (5 ϫ 10 6 ) were electroporated with 20 g of linearized node cells, and bone marrow cells from 6-to 10-week-old mice targeting vector TV30neoA DNA (340 V, 250 F; Bio-Rad Gene were prepared as described previously (Wallace et al., 1992) , resusPulser). G418 (300 g/ml) selection was started 48 hr after transfecpended in PBS, and incubated with appropriate MAbs for 30 min tion, and G418-resistant colonies were obtained after 10 days. PCR at 4ЊC. Stained cells were analyzed using a FACScan flow cytometer screening for homologous recombination was carried out as de-(Becton-Dickinson). scribed previously (Fung-Leung et al., 1991) . A primer specific for the neo resistance gene (5Ј-TATCAGGACATAGCGTTGGC-3Ј) and an outside primer specific for the CD30 gene (5Ј-CAACCCTGGCTGA T Cell Stimulation Assay T cells were isolated from spleens and lymph nodes of CD30 ϩ/Ϫ and GTTACTCTACCC-3Ј) upstream of the construct were used in PCR. Homologous recombination was subsequently confirmed by EcoRI CD30 Ϫ/Ϫ mice using columns to negatively enrich for T cells (R&D Systems). Purified T cells (1 ϫ 10 5 ) were placed into flat-bottomed digestion of genomic DNA and hybridization with probe A ( Figure  1A ). Chimeric mice were produced by injection of embryonic cells 96-well plates containing 5 ϫ 10 5 irradiated (2000 rads) splenic feeder cells and freshly prepared Iscove's modified Dulbecco's meinto 3.5-day-old blastocysts as described previously ( (Kundig et al., 1993a (1984) . A and 12 days, sera were collected, and neutralizing antibody titers Hodgkin cell-specific antigen is expressed on a subset of auto-and were determined as described previously (Binder and Kundig, 1991) . ) in the Caligariscappio, F., Bertero, M.T., Converso, M., Stacchini, A., Visame conditions as described above for H-Y TCR-transgenic mice.
nante, F., Romagnani, S., and Pizzolo, G. (1995) . Circulating levels Responder cells were also cultured without stimulators to determine of soluble CD30, a marker of cells producing TH2-type cytokines, background proliferation. After 3 days, responder lymph nodes and are increased in patients with systemic lupus-erythematosus and spleen cells were harvested after a 16 hr pulse with Del Prete, G., De Carli, M., Almerigogna, F., Daniel, C.K., D'Elios, azide free; Pharmingen) were placed on a plate and incubated at M.M., Zancuoghi, G., Vinante, F., Pizzolo, G., and Romagnani, S. 37ЊC for 2 hr. The plates were washed three times with PBS. Thymo-(1995) . Preferential expression of CD30 by human CD4 ϩ T cells cytes (5 ϫ 10 6 ) from CD30 ϩ/ϩ or CD30 Ϫ/Ϫ mice were treated with producing Th2-type cytokines. FASEB J. 9, 81-86. dexamethasone (1 M) or coated anti-CD3 antibodies for 24 hr. Cells were collected by centrifugation at 1000 rpm at 4ЊC for 10 Dent, A.L., Matis, L.A., Hooshmand, F., Widacki, S.M., Bluestone, min. Cells were resuspended in 0.5 ml of TTE solution (10 mM EDTA, J.A., and Hedrick, S.M. (1990). Self-reactive ␥␦ T cells are eliminated 50 mM Tris [pH 8.0], 0.5% Triton X-100) with 0.5 mg of proteinase in the thymus. Nature 343, 714-719. K and incubated for 2 hr at 50ЊC. DNA samples were extracted twice DiSanto, J.P., Bonnefoy, J.Y., Gauchat, J.F., Fischer, A., and de with phenol-chloroform and precipitated with isopropanol. The DNA Saint Basile, G. (1993) . CD40 ligand mutations in X-linked immunowas collected by centrifugation at 13,000 ϫ g at 4ЊC for 10 min.
deficiency with hyper-IgM. Nature 361, 541-543. DNA pellets were washed in 70% ethanol. DNA samples (20 l) Dü rkop, H., Latza, U., Hummel, M., Eitelbach, F., Seed, B., and Stein, were electrophoresed on a 1% agarose gel containing 0.05 g/ml H. (1992) . Molecular cloning and expression of a new member of ethidium bromide.
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